Related Experiment Videos

Long-term response to maintenance treatment with rituximab in CD20(+) multiple myeloma

Leukemia & Lymphoma

|September 3, 2010

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

t(14;19)(q32;q13) breakpoints telomeric to BCL3 on 19q13.32 in B-cell lymphomas other than chronic lymphocytic leukemia and long-range structures of der(19)t(14;19) based on optical genome mapping.

Leukemia & lymphoma·2026

Genetic analysis of cell-free DNA in follicular lymphoma in comparison with tissue-derived DNA.

Leukemia & lymphoma·2025

Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study.

Ophthalmology and therapy·2025

Composite mantle cell lymphoma with cryptic ins(11;2)(q13;p11.2p11.2)/IGK::CCND1 and lymphoplasmacytic lymphoma with MYD88 L265P mutation.

Cancer genetics·2025

Two recurrent types of IGH::5' BCL2 breakpoints representing cytogenetic ins(14;18)(q32;q21q21) and t(14;18)(q32;q21), mediated by the VDJ and class switch recombination processes, respectively.

Leukemia & lymphoma·2024

Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization.

Journal of clinical and experimental hematopathology : JCEH·2024

See all related articles